Document 3200 DOCN M94A3200 TI A trial to establish a novel mouse model for AIDS. DT 9412 AU Yoshimoto T; Nagase H; Kojima K; Kanamori Y; Nariuchi H; Department of Allergology, Institute of Medical Science,; University of Tokyo, Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(1):130 (abstract no. PA0141). Unique Identifier : AIDSLINE ICA10/94369375 AB OBJECTIVE: To try to establish a novel mouse model for AIDS, we analyzed various immunological parameters of DDD/1 mice subcutaneously injected with a mouse mammary tumor virus, MMTV (FM), which we have recently isolated and has strong superantigenic activity reacting to V beta 8.2+ T cells. METHODS: After subcutaneous injection of MMTV (FM) into four footpads of DDD/1 mice, draining lymph nodes and spleen were analyzed at a given time for their cell number, composition of subsets and mitogenic response against anti-CD3 antibody. Histological analysis of these tissues was also performed. RESULTS: The draining lymph nodes gradually became enlarged approximately 10-30 times in size and the percentage of V beta 8.2+ T cells reached to around 50% in CD4+ T cells by 3 week after the injection. Spleen also became enlarged approximately 5-folds bigger than control by 6 weeks after the injection. The mitogenic response of spleen obtained from mouse injected with MMTV (FM) was significantly reduced compared to that of control. DISCUSSION AND CONCLUSIONS: The subcutaneous injection of MMTV (FM) into footpads of DDD/1 mice was revealed to induce lymphoadenopathy, splenomegaly and depressed immune response. Although further studies are currently in progress, these results suggest that DDD/1 mice injected with MMTV (FM) have a potential to be used as a novel mouse model for AIDS. DE Acquired Immunodeficiency Syndrome/*IMMUNOLOGY/PATHOLOGY Animal Comparative Study Disease Models, Animal Lymph Nodes/IMMUNOLOGY/PATHOLOGY Lymphocyte Subsets/IMMUNOLOGY Lymphocyte Transformation Mammary Tumor Viruses, Mouse/*PATHOGENICITY Mice Mice, Inbred Strains Reference Values Spleen/IMMUNOLOGY/PATHOLOGY Splenomegaly MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).